Anavex
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.About AVXL
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome.
AVXL Key Statistics
Stock Snapshot
Anavex(AVXL) stock is priced at $3.66, giving the company a market capitalization of 314.25M. It carries a P/E multiple of -10.04.
As of 2025-11-14, Anavex(AVXL) stock has fluctuated between $2.61 and $6.00. The current price stands at $3.66, placing the stock +40.2% above today's low and -39.0% off the high.
The Anavex(AVXL)'s current trading volume is 21.54M, compared to an average daily volume of 2.57M.
During the past year, Anavex(AVXL) stock moved between $2.61 at its lowest and $14.44 at its peak.
During the past year, Anavex(AVXL) stock moved between $2.61 at its lowest and $14.44 at its peak.
AVXL News
Anavex Life Sciences (AVXL) stock plummeted on Friday after the clinical-stage biopharmaceutical company announced a regulatory update concerning oral blarcames...
Anavex (AVXL) Life Sciences provides a regulatory update on blarcamesine for early Alzheimer’s disease. The Company was informed by the Committee for Medicinal...